Biologic agents used for rheumatic disease
| Anti-tumor necrosis factor alpha agents Adalimumab Certolizumab Etanercept Golimumab Infliximab |
| Interleukin 1 receptor antagonists Anakinra Canakinumab Rilonacept |
| Anti-interleukin 5 antibody Mepolizumab |
| Interleukin 6 receptor antagonists Sarilumab Tocilizumab |
| Interleukin 12/23 antagonist Ustekinumab |
| Interleukin 17 antagonists Ixekizumab Secukinumab |
| T-cell costimulation blocker Abatacept |
| Anti-CD20 antibody Rituximab |
| Anti-B-cell activating factor (B-lymphocyte stimulator) antibody Belimumab |